The lncRNA MEG3 is known to function as a tumor suppressor in glioma by reducing MDM2 gene expression, leading to p53 tumor suppressor protein stabilization and over-expression, and glioma cell growth arrest and programmed cell death [57]. This evidence concerns the gene MEG3 and central nervous system cancer.